A tighter archive for life-science signals.
Search once, then narrow by source or topic.
In the clinic for March 4, 2026
In the clinic for March 4, 2026
Other news to note for March 4, 2026
Other news to note for March 4, 2026
Regulatory actions for March 4, 2026
Regulatory actions for March 4, 2026
Sanofi licenses Sino Biopharm’s JAK/ROCK drug for $1.4B
Sanofi licenses Sino Biopharm’s JAK/ROCK drug for $1.4B
China approves first noninvasive therapy for cervical precancer
China approves first noninvasive therapy for cervical precancer
Moderna to pay up to $2.25B to settle COVID-19 patents case
Moderna to pay up to $2.25B to settle COVID-19 patents case
Moderna to pay up to $2.25B to settle COVID-19 patents case
Moderna to pay up to $2.25B to settle COVID-19 patents case
GSK nabs two Frontier Biotech siRNA assets in $1B deal
GSK nabs two Frontier Biotech siRNA assets in $1B deal
Wave of deals lifts large-cap biopharma stocks
Wave of deals lifts large-cap biopharma stocks
US taking a closer look at China biotech subsidies
US taking a closer look at China biotech subsidies
Systimmune’s iza-bren hits phase III breast cancer goals in China
Systimmune’s iza-bren hits phase III breast cancer goals in China
Returning to pulmonary hypertension, GSK buys 35Pharma
Returning to pulmonary hypertension, GSK buys 35Pharma
Financings for March 3, 2026
Financings for March 3, 2026
In the clinic for March 3, 2026
In the clinic for March 3, 2026
Other news to note for March 3, 2026
Other news to note for March 3, 2026
Regulatory actions for March 3, 2026
Regulatory actions for March 3, 2026
Appointments and advancements for March 2, 2026
Appointments and advancements for March 2, 2026
Financings for March 2, 2026
Financings for March 2, 2026
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page